SPL 0.00% 8.9¢ starpharma holdings limited

He also talked about BIND014 system. They failed in the...

  1. 54 Posts.
    He also talked about BIND014 system. They failed in the BIND-Docetaxel which had nasty side effects in phase 1. You can compare to our DEP-DOX to see huge difference in term of hematologic toxicities . I think the main reason is that BIND system using uncontrolled PEG stealth. The layer made the nanoparticle unstable and bigger, so the whole system was getting easier to fall apart once circulating in blood stream.
    Here is link for BIND-Docetaxel
    https://www.ncbi.nlm.nih.gov/pubmed/26847057
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
8.9¢
Change
0.000(0.00%)
Mkt cap ! $36.67M
Open High Low Value Volume
9.0¢ 9.1¢ 8.7¢ $257.5K 2.884M

Buyers (Bids)

No. Vol. Price($)
3 119243 8.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 60378 1
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.